News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,181 Results
Type
Article (43957)
Company Profile (313)
Press Release (700896)
Multimedia
Podcasts (119)
Webinars (22)
Section
Business (211041)
Career Advice (2110)
Deals (36768)
Drug Delivery (131)
Drug Development (83461)
Employer Resources (176)
FDA (16867)
Job Trends (15513)
News (357511)
Policy (34145)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2625)
Accelerated approval (38)
Adcomms (27)
Allergies (161)
Alliances (51586)
ALS (191)
Alzheimer's disease (1741)
Antibody-drug conjugate (ADC) (366)
Approvals (17156)
Artificial intelligence (594)
Autoimmune disease (210)
Automation (46)
Bankruptcy (372)
Best Places to Work (11769)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (187)
Bladder cancer (174)
Brain cancer (65)
Breast cancer (687)
Cancer (5251)
Cardiovascular disease (447)
Career advice (1792)
Career pathing (39)
CAR-T (296)
CDC (54)
Celiac Disease (2)
Cell therapy (795)
Cervical cancer (40)
Clinical research (71607)
Collaboration (1884)
Company closure (4)
Compensation (1248)
Complete response letters (77)
COVID-19 (2796)
CRISPR (104)
C-suite (963)
Cystic fibrosis (150)
Data (6833)
Decentralized trials (2)
Denatured (36)
Depression (151)
Diabetes (543)
Diagnostics (6885)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (284)
Drug pricing (208)
Drug shortages (31)
Duchenne muscular dystrophy (266)
Earnings (92564)
Editorial (62)
Employer branding (21)
Employer resources (155)
Events (121078)
Executive appointments (1042)
FDA (20216)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1578)
Gene editing (216)
Generative AI (49)
Gene therapy (660)
GLP-1 (1047)
Government (4828)
Grass and pollen (7)
Guidances (392)
Healthcare (19092)
HIV (70)
Huntington's disease (52)
IgA nephropathy (89)
Immunology and inflammation (274)
Immuno-oncology (77)
Indications (149)
Infectious disease (3100)
Inflammatory bowel disease (206)
Inflation Reduction Act (14)
Influenza (124)
Intellectual property (272)
Interviews (327)
IPO (16926)
IRA (57)
Job creations (4071)
Job search strategy (1499)
JPM (65)
Kidney cancer (18)
Labor market (91)
Layoffs (580)
Leadership (35)
Legal (8425)
Liver cancer (95)
Longevity (25)
Lung cancer (700)
Lymphoma (398)
Machine learning (52)
Management (60)
Manufacturing (908)
MASH (179)
Medical device (13916)
Medtech (13988)
Mergers & acquisitions (20973)
Metabolic disorders (1407)
mRNA (181)
Multiple sclerosis (171)
NASH (18)
Neurodegenerative disease (369)
Neuropsychiatric disorders (96)
Neuroscience (3113)
Neurotech (1)
NextGen: Class of 2026 (6646)
Non-profit (4570)
Now hiring (72)
Obesity (666)
Opinion (297)
Ovarian cancer (177)
Pain (238)
Pancreatic cancer (249)
Parkinson's disease (324)
Partnered (34)
Patents (544)
Patient recruitment (562)
Peanut (63)
People (61155)
Pharmaceutical (86)
Pharmacy benefit managers (32)
Phase 1 (22223)
Phase 2 (31490)
Phase 3 (23592)
Pipeline (6582)
Policy (318)
Postmarket research (2655)
Preclinical (9454)
Press Release (68)
Prostate cancer (269)
Psychedelics (51)
Radiopharmaceuticals (302)
Rare diseases (983)
Real estate (6308)
Recruiting (72)
Regulatory (25712)
Reports (54)
Research institute (2452)
Resumes & cover letters (362)
Rett syndrome (32)
RNA editing (17)
RSV (83)
Schizophrenia (163)
Series A (266)
Series B (198)
Service/supplier (11)
Sickle cell disease (105)
Special edition (25)
Spinal muscular atrophy (163)
Sponsored (44)
Startups (3772)
State (2)
Stomach cancer (19)
Supply chain (116)
Tariffs (96)
The Weekly (81)
Vaccines (1062)
Venture capital (95)
Weight loss (433)
Women's health (107)
Worklife (19)
Date
Last 7 days (581)
Last 30 days (2854)
Last 365 days (30333)
2026 (6848)
2025 (30678)
2024 (35762)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33136)
2016 (32663)
2015 (38617)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (801)
Alabama (87)
Alaska (7)
Arizona (331)
Arkansas (15)
Asia (42304)
Australia (6777)
California (12076)
Canada (3467)
China (1211)
Colorado (511)
Connecticut (517)
Delaware (361)
Europe (90873)
Florida (1817)
Georgia (381)
Hawaii (3)
Idaho (61)
Illinois (949)
India (77)
Indiana (560)
Iowa (22)
Japan (477)
Kansas (128)
Kentucky (43)
Louisiana (34)
Maine (73)
Maryland (1470)
Massachusetts (8684)
Michigan (342)
Minnesota (658)
Mississippi (6)
Missouri (135)
Montana (33)
Nebraska (29)
Nevada (133)
New Hampshire (81)
New Jersey (3206)
New Mexico (29)
New York (3180)
North Carolina (1553)
North Dakota (8)
Northern California (5945)
Ohio (358)
Oklahoma (22)
Oregon (46)
Pennsylvania (2440)
Puerto Rico (25)
Rhode Island (50)
South America (1178)
South Carolina (73)
South Dakota (1)
Southern California (4734)
Tennessee (195)
Texas (1882)
United States (42861)
Utah (364)
Vermont (1)
Virginia (298)
Washington D.C. (80)
Washington State (971)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
745,181 Results for "oramed pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase
October 2, 2025
·
7 min read
Pharm Country
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - June 26, 2024
Oramed Pharmaceuticals Inc. announced today that its Board of Directors has authorized a common stock repurchase plan allowing for the buy-back of up to $20,000,000 in maximum value of its common stock through open market purchases, privately-negotiated transactions, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, over the next 12 months.
June 26, 2024
·
4 min read
Pharm Country
Oramed Letter to Shareholders - June 26, 2024
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron.
June 26, 2024
·
7 min read
Press Releases
Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. secure public reimbursement of ABILIFY ASIMTUFII®
March 4, 2026
·
6 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - March 18, 2026
March 18, 2026
·
4 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Press Releases
Kenox Pharmaceuticals Inc. Announces Clinical Manufacturing Readiness for Nasal and Inhaled Drug Products
March 5, 2026
·
2 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
March 13, 2026
·
13 min read
Press Releases
Eric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc.
March 9, 2026
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026
March 19, 2026
·
3 min read
1 of 74,519
Next
